Control of hypercalcaemia of parathyroid carcinoma by immunisation

Lancet

Volumn 353, Issue 9150, 1999, Pages 370-373

  Bradwell, Arthur R ^a   Harvey, Timothy C ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b MANOR HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; CALCIUM ION; PARATHYROID HORMONE; RECEPTOR;

ADULT; ALBRIGHT SYNDROME; ANTIBODY PRODUCTION; ARTICLE; BONE; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYPERCALCEMIA; IMMUNIZATION; LUNG METASTASIS; PARATHYROID CARCINOMA; PLEURA METASTASIS; PRIORITY JOURNAL;

EID: 0033616471     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)06469-1     Document Type: Article

References (19)

1. Anderson B.J., Samaan N.A., Vassilopoulou-Sellin R., Ordonez N.G., Hickey R.C. Parathyroid carcinoma: features and difficulties in diagnosis and management. Surgery. 94:1983;906-915.
2. Schantz A., Castleman B. Parathyroid carcinoma: a study of 70 cases. Cancer. 31:1973;600-605.
3. Wynne A.G., Van Heerden J., Carney J.A., Fitzpatrick L.A. Parathyroid carcinoma: clinical and pathological features in 43 patients. Medicine. 71:1992;197-205.
4. Sandelin K., Thompson N.W., Bondeson L. Metastatic parathyroid carcinoma: dilemmas in management. Surgery. 110:1991;978-988.
5. Collins M.T., Skarulis M.C., Bilezikian J.P., et al. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab. 83:1998;1083-1088.
6. Tam J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA. 85:1988;5409-5413.
7. Harlow E, Lane D. Antibodies; A Laboratory Manual. New York: Cold Spring Harbor Laboratory, 1988: 178-79.
8. Juppner H., Schipani E., Bringhurst F.R., et al. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34). Endocrinology. 134:1994;879-884.
9. Martin K.J., Hruska K.A., Freitag J.J., Klahr S., Slatopolsky E. The peripheral metabolism of parathyroid hormone. N Engl J Med. 301:1979;1092-1098.
10. Bringhurst F.R., Stern A.M., Yotts M., et al. Peripheral metabolism of PTH: fate of biologically active amino terminus in vivo. Am J Physiol. 255:1988;E886-893.
11. Wang R., Charoenvit Y., Corradin Get al. Induction of protective polyclonal antibodies by immunisation with a Plasmodium yoelli circumsporozoite protein multiple antigen peptide vaccine. J Immunol. 154:1995;2784-2793.
12. Mamula M.J., Rong-Hwa L., Janeway C.A. Jr., Hardin J.A. Breaking T cell tolerance with foreign and self co-immunogens. J Immunol. 149:1992;789-795.
13. Grillot D., Valmori D., Lambert P-H, Corradin G., Giudice G.D. Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes. Infect Immun. 61:1993;3064-3067.
14. MacLennan R., Schofield F.D., Pittman M., Hardegree M.C., Barile M.F. Immunisation against neonatal tetanus in New Guinea: antitoxin response of pregnant women to adjuvant and plain toxoids. Bull World Health Organ. 32:1965;683-697.
15. Stewart T.H., Hollinshead A.C., Harris J.E., et al. Immunochemotherapy of lung cancer. Ann NY Acad Sci. 277:1976;436-466.
16. Hollinshead A., Takita H., Stewart T., Sankaranarayanan R. Specific active lung cancer immunotherapy: immune correlates of clinical responses and an update of immunotherapy trials evaluations. Cancer. 62:1988;1662-1671.
17. Fishman P., Merimski O., Baharav E., Schoenfeld Y. Autoantibodies to tyrosinase. Cancer. 79:1997;1461-1464.
18. Shu S., Plautz G.E., Krauss J.C., Chang A.E. Tumor immunology. JAMA. 278:1997;1972-1981.
19. Pol S., Driss F., Michel M.-L., et al. Specific vaccine therapy in chronic hepatitis B infection. Lancet. 344:1994;342.